1 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Stefan Lujinschi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients Observational Assessment - Pulmonary Hypertension (PH), End Stage Kidney Disease (ESRD) | Not yet recruiting | Stefan Lujinschi | 30 | 2026-07-01 | 2026-06-30 | |
| Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) Observational assessment - Periodontal Disease, Periodontitis | Recruiting | Stefan Lujinschi | 100 | 2026-05-04 | 2026-06-26 | |
| Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) Treatment with Spironolactone followed by Dapagliflozin followed by their combination, Treatment with Dapagliflozin followed by Spironolactone followed by their combination - Alport Syndrome, Thin Basement Membrane Disease | Phase 4 | Completed | Stefan Lujinschi | 12 | 2024-02-26 | 2026-06-25 |
Nephritis, Hereditary (2) · Renal Insufficiency, Chronic (2) · Albuminuria (1) · Edema (1) · Fabry Disease (1) · Hematuria, Benign Familial (1) · Hypertension, Pulmonary (1) · Kidney Failure, Chronic (1) · Lupus Erythematosus, Systemic (1) · Periodontal Diseases (1) · Periodontitis (1) · Tuberous Sclerosis (1)
Therapeutics (1)
Romania (3)
Gener Ismail, Professor, MD, PhD (2) · Bahtiar Ismail, MD, PhD (1) · Georgiana N Olaru, MD (1) · Ioan M Coman, Professor, MD, PhD (1)